PA
FMI

Parallel Advisors’s Foundation Medicine, Inc. FMI Stock Holding History

Parallel Advisors’s Portfolio FMI Stock Details FMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-166
Closed -$6K – 2319
2017
Q2 		$6K Hold
166
– – ﹤0.01% 1566
2017
Q1 		$6K Hold
166
– – ﹤0.01% 1461
2016
Q4 		$3K Buy
+166
New +$3.58K ﹤0.01% 1578

Other funds holding FMI

GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
DGI
Discovery Group I Chicago, Illinois $262M AUM 29.24% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Parallel Advisors's FMI Position: Q3 2017 in Review

Parallel Advisors sold out of Foundation Medicine, Inc. (FMI) in Q3 2017, closing a stake of 166 shares — an estimated $6K sold.

Parallel Advisors first reported a position in FMI in Q4 2016 and held it in 3 quarters. The position peaked at $6K in Q2 2017. 97 funds tracked by Wall St. Rank hold FMI as of Q3 2017.

  • Parallel Advisors reported no remaining Foundation Medicine, Inc. position as of Q3 2017 after selling out during the quarter.
  • Parallel Advisors sold 166 Foundation Medicine, Inc. shares in Q3 2017, an estimated $6K.
  • Parallel Advisors first reported a position in Foundation Medicine, Inc. in Q4 2016 and held it in 3 quarters.
  • Parallel Advisors's Foundation Medicine, Inc. position peaked at $6K in Q2 2017.
  • 97 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2017.

Based on Parallel Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.